Latest Breaking News On - Calidi neuronova - Page 1 : comparemela.com

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

SAN DIEGO (BUSINESS WIRE) May 1, 2024

United statesSan diegoCalidi biotherapeuticsStephen thesingCalidi neuronovaStephen jasperCompany registrationGilmartin groupAmerican society of clinical oncologyCalidi biotherapeutics incClinical oncologyAnnual meetingHope led phaseCentral nervous systemDevelopmental therapeuticsNote regarding forward looking

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoOrange countyInstagramand linkedinLos angelesAllan camaisaKaren aboodyCalidi biotherapeuticsCalidi neuronovaCalidi biotherapeutics incNational cancerProduct serviceDepartment of stem cell biologyCompany registrationDivision of neurosurgeryTranslational genomics research institute

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Company to also share progress with cell-based virotherapy platforms for advanced solid tumors .

United statesSan diegoCalidi biotherapeuticsAntoniof santidrian pharmBorisr minevAntoniof santidrianJana portnowCalidi neuronovaOncolytic virotherapyOncolytic virotherapiesScientific affairsNorthwestern universityScientific affairs of calidi biotherapeuticsCalidi biotherapeutics incDepartment of medical oncology therapeutics researchCity of hope comprehensive cancer center presentation

Calidi Biotherapeutics and Edoc Acquisition Corp Agree to

-Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, combining $25 million PIPE and up to $92 million.

New yorkUnited statesLa jollaAllan camaisaCalidi biotherapeuticsKevin chenCalidi neuronovaExchange commissionEdoc acquisition corpSecurities incCalidi biotherapeutics incHc wainwright coLewis brisbois bisgaard smithEllenoff grossman scholeEdoc acquisitionNasdaq capital